Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | growth factor receptor-bound protein | 0.0067 | 0.0062 | 0.0082 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 2 | 0.052 | 0.2002 | 0.2535 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0076 | 0.0102 | 0.0053 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0076 | 0.0102 | 0.0053 |
Brugia malayi | Sex muscle abnormal protein 5 | 0.0067 | 0.0062 | 0.0062 |
Brugia malayi | Variant SH3 domain containing protein | 0.0067 | 0.0062 | 0.0062 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.1151 | 0.4695 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2392 | 1 | 1 |
Echinococcus multilocularis | tyrosine protein kinase Src64B | 0.0076 | 0.0102 | 0.0053 |
Schistosoma mansoni | tyrosine kinase | 0.0076 | 0.0102 | 0.0135 |
Onchocerca volvulus | 0.0273 | 0.0945 | 0.5 | |
Onchocerca volvulus | 0.0273 | 0.0945 | 0.5 | |
Brugia malayi | Choline O-acetyltransferase | 0.0273 | 0.0945 | 0.0945 |
Echinococcus granulosus | tyrosine protein kinase Src64B | 0.0076 | 0.0102 | 0.0053 |
Schistosoma mansoni | tyrosine kinase | 0.0076 | 0.0102 | 0.0135 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0062 | 0.0062 |
Echinococcus multilocularis | proto oncogene tyrosine protein kinase LCK | 0.0076 | 0.0102 | 0.0053 |
Schistosoma mansoni | adapter molecule crk | 0.0067 | 0.0062 | 0.0082 |
Onchocerca volvulus | 0.0273 | 0.0945 | 0.5 | |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0076 | 0.0102 | 0.0053 |
Loa Loa (eye worm) | sex muscle abnormal protein 5 | 0.0067 | 0.0062 | 0.0062 |
Echinococcus granulosus | carnitine O palmitoyltransferase 2 | 0.052 | 0.2002 | 0.2535 |
Loa Loa (eye worm) | choline O-acetyltransferase | 0.0273 | 0.0945 | 0.0945 |
Schistosoma mansoni | proto-oncogene tyrosine-protein kinase src | 0.0076 | 0.0102 | 0.0135 |
Echinococcus multilocularis | tyrosine protein kinase lyn lyn a protein tyrosine kinase lymphocyte specific protein tyrosine kinase | 0.0076 | 0.0102 | 0.0053 |
Echinococcus granulosus | tyrosine protein kinase Lyn | 0.0076 | 0.0102 | 0.0053 |
Schistosoma mansoni | choline o-acyltransferase | 0.0273 | 0.0945 | 0.1247 |
Trypanosoma brucei | carnitine O-palmitoyltransferase II, putative | 0.052 | 0.2002 | 1 |
Echinococcus multilocularis | tyrosine protein kinase Src42A | 0.0076 | 0.0102 | 0.0053 |
Schistosoma mansoni | proto-oncogene tyrosine-protein kinase abl1 | 0.0067 | 0.0062 | 0.0082 |
Loa Loa (eye worm) | variant SH3 domain-containing protein | 0.0067 | 0.0062 | 0.0062 |
Loa Loa (eye worm) | SRC-1 | 0.0076 | 0.0102 | 0.0102 |
Schistosoma mansoni | choline o-acyltransferase | 0.0273 | 0.0945 | 0.1247 |
Leishmania major | carnitine palmitoyltransferase-like protein | 0.052 | 0.2002 | 0.2819 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.052 | 0.2002 | 0.2002 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 1, liver | 0.1151 | 0.4695 | 0.6054 |
Schistosoma mansoni | tyrosine kinase | 0.0076 | 0.0102 | 0.0135 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0273 | 0.0945 | 0.0945 |
Trypanosoma cruzi | carnitine O-palmitoyltransferase II, putative | 0.052 | 0.2002 | 0.2819 |
Brugia malayi | Variant SH3 domain containing protein | 0.0067 | 0.0062 | 0.0062 |
Schistosoma mansoni | tyrosine kinase | 0.1824 | 0.7574 | 1 |
Echinococcus multilocularis | tyrosine protein kinase Btk29A | 0.1857 | 0.7715 | 1 |
Leishmania major | choline/Carnitine o-acyltransferase-like protein | 0.1151 | 0.4695 | 1 |
Echinococcus granulosus | c src tyrosine kinase | 0.0076 | 0.0102 | 0.0053 |
Schistosoma mansoni | tyrosine kinase | 0.0076 | 0.0102 | 0.0135 |
Schistosoma mansoni | growth factor receptor-bound protein | 0.0067 | 0.0062 | 0.0082 |
Echinococcus multilocularis | tyrosine protein kinase lyn tyrosine protein kinase blk | 0.0076 | 0.0102 | 0.0053 |
Echinococcus multilocularis | c src tyrosine kinase | 0.0076 | 0.0102 | 0.0053 |
Loa Loa (eye worm) | carnitine O-palmitoyltransferase I isoform | 0.0273 | 0.0945 | 0.0945 |
Echinococcus granulosus | tyrosine protein kinase Btk29A | 0.1857 | 0.7715 | 1 |
Echinococcus multilocularis | tyrosine protein kinase Abl | 0.0076 | 0.0102 | 0.0053 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0076 | 0.0102 | 0.0102 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.1151 | 0.4695 | 1 |
Schistosoma mansoni | nck2/grb4 | 0.0067 | 0.0062 | 0.0082 |
Echinococcus multilocularis | tyrosine protein kinase Fgr | 0.0076 | 0.0102 | 0.0053 |
Loa Loa (eye worm) | choline/Carnitine O-acyltransferase | 0.052 | 0.2002 | 0.2002 |
Brugia malayi | Choline O-acetyltransferase | 0.0273 | 0.0945 | 0.0945 |
Echinococcus granulosus | choline O acetyltransferase | 0.0273 | 0.0945 | 0.1153 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0076 | 0.0102 | 0.0053 |
Onchocerca volvulus | 0.0273 | 0.0945 | 0.5 | |
Echinococcus granulosus | 3'partial|tyrosine protein kinase Fgr | 0.0076 | 0.0102 | 0.0053 |
Brugia malayi | SRC-1 | 0.0076 | 0.0102 | 0.0102 |
Echinococcus granulosus | tyrosine protein kinase Src42A | 0.0076 | 0.0102 | 0.0053 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0076 | 0.0102 | 0.0053 |
Echinococcus granulosus | carnitine O palmitoyltransferase 1 liver | 0.1151 | 0.4695 | 0.6054 |
Loa Loa (eye worm) | hypothetical protein | 0.0273 | 0.0945 | 0.0945 |
Echinococcus multilocularis | choline O acetyltransferase | 0.0273 | 0.0945 | 0.1153 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0076 | 0.0102 | 0.0053 |
Echinococcus granulosus | proto oncogene tyrosine protein kinase LCK | 0.0076 | 0.0102 | 0.0053 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.